Häberle J, Rubio V (2022) Disorders of the Urea Cycle and Related Enzymes. 391–405. https://doi.org/10.1007/978-3-662-63123-2_19 

Hayasaka K (2021) Metabolic basis and treatment of citrin deficiency. J Inherit Metab Dis 44:110–117. https://doi.org/10.1002/jimd.12294 

Imamura Y, Kobayashi K, Shibatou T, et al (2003) Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol Res 26:68–72. https://doi.org/10.1016/s1386-6346(02)00331-5 

Kido J, Häberle J, Sugawara K, et al (2022) Clinical manifestation and long‐term outcome of citrin deficiency: Report from a nationwide study in Japan. J Inherit Metab Dis. https://doi.org/10.1002/jimd.12483 

Okano Y, Ohura T, Sakamoto O, Inui A (2019) Current treatment for citrin deficiency during NICCD and adaptation/compensation stages: Strategy to prevent CTLN2. Mol Genet Metab 127:175–183. https://doi.org/10.1016/j.ymgme.2019.06.004 

Saheki T, Moriyama M, Funahashi A, Kuroda E (2020) AGC2 (Citrin) Deficiency—From Recognition of the Disease till Construction of Therapeutic Procedures. Biomol 10:1100. https://doi.org/10.3390/biom10081100 

Saheki T, Song Y (2017) Citrin Deficiency. https://www.ncbi.nlm.nih.gov/books/NBK1181/ 

Shiohama N, Sugita Y, Imamura N, et al (1993) [Type II citrullinemia triggered by acetaminophen]. Nō Shinkei Brain Nerve 45:865–70 

Tamakawa S, Nakamura H, Katano T, et al (1994) Hyperalimentation Therapy Produces a Comatose State in a Patient with Citrullinemia. J Jpn Soc Intensive Care Medicine 1:37–41. https://doi.org/10.3918/jsicm.1.37 

Yazaki M, Takei Y, Kobayashi K, et al (2005) Risk of Worsened Encephalopathy after Intravenous Glycerol Therapy in Patients with Adult-onset Type II Citrullinemia (CTLN2). Internal Med 44:188–195. https://doi.org/10.2169/internalmedicine.44.188